Detailed Research: Economic Perspectives on Southern, AcelRx Pharmaceuticals, International Flavors & Fragrances, Pandora Media, Express Scripts Holding, and United Continental — What Drives Growth in Today's Competitive Landscape

12-06-2018

NEW YORK, June 12, 2018 (GLOBE NEWSWIRE) -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors, traders, and shareholders of Southern Company (NYSE:SO), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), International Flavors & Fragrances, Inc. (NYSE:IFF), Pandora Media, Inc. (NYSE:P), Express Scripts Holding Company (NASDAQ:ESRX), and United Continental Holdings, Inc. (NYSE:UAL), including updated fundamental summaries, consolidated fiscal reporting, and fully-qualified certified analyst research.

Complimentary Access: Research Reports

Full copies of recently published reports are available to readers at the links below.

SO DOWNLOAD: https://Fundamental-Markets.com/register/?so=SO
ACRX DOWNLOAD:
https://Fundamental-Markets.com/register/?so=ACRX
IFF DOWNLOAD:
https://Fundamental-Markets.com/register/?so=IFF
P DOWNLOAD:
https://Fundamental-Markets.com/register/?so=P
ESRX DOWNLOAD:
https://Fundamental-Markets.com/register/?so=ESRX
UAL DOWNLOAD:
https://Fundamental-Markets.com/register/?so=UAL

(You may have to copy and paste the link into your browser and hit the [ENTER] key)

The new research reports from Fundamental Markets, available for free download at the links above, examine Southern Company (NYSE:SO), AcelRx Pharmaceuticals, Inc. (NASDAQ:ACRX), International Flavors & Fragrances, Inc. (NYSE:IFF), Pandora Media, Inc. (NYSE:P), Express Scripts Holding Company (NASDAQ:ESRX), and United Continental Holdings, Inc. (NYSE:UAL) on a fundamental level and outlines the overall demand for their products and services in addition to an in-depth review of the business strategy, management discussion, and overall direction going forward. Several excerpts from the recently released reports are available to today's readers below.

-----------------------------------------

Important Notice: the following excerpts are not designed to be standalone summaries and as such, important information may be missing from these samples. Please download the entire research report, free of charge, to ensure you are reading all relevant material information. All information in this release was accessed June 8th, 2018. Percentage calculations are performed after rounding. All amounts in millions (MM), except per share amounts.

-----------------------------------------

Southern Company (SO) REPORT OVERVIEW

Southern's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Southern reported revenue of $6,372.00MM vs $5,771.00MM (up 10.41%) and basic earnings per share $0.93 vs $0.66 (up 40.91%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Southern reported revenue of $23,031.00MM vs $19,896.00MM (up 15.76%) and basic earnings per share $0.84 vs $2.57 (down 67.32%). Southern is expected to report earnings on August 1st, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $0.73. The estimated EPS forecast for the next fiscal year is $3.00 and is expected to report on February 20th, 2019.

To read the full Southern Company (SO) report, download it here: https://Fundamental-Markets.com/register/?so=SO

-----------------------------------------

AcelRx Pharmaceuticals, Inc. (ACRX) REPORT OVERVIEW

AcelRx Pharmaceuticals' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, AcelRx Pharmaceuticals reported revenue of $0.34MM vs $3.11MM (down 88.97%) and basic earnings per share -$0.23 vs -$0.34. For the twelve months ended December 31st, 2017 vs December 31st, 2016, AcelRx Pharmaceuticals reported revenue of $8.00MM vs $17.36MM (down 53.94%) and basic earnings per share -$1.10 vs -$0.95. AcelRx Pharmaceuticals is expected to report earnings on August 7th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was -$0.29. The estimated EPS forecast for the next fiscal year is -$0.75 and is expected to report on March 14th, 2019.

To read the full AcelRx Pharmaceuticals, Inc. (ACRX) report, download it here: https://Fundamental-Markets.com/register/?so=ACRX

-----------------------------------------

International Flavors & Fragrances, Inc. (IFF) REPORT OVERVIEW

International Flavors & Fragrances' Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, International Flavors & Fragrances reported revenue of $930.93MM vs $828.29MM (up 12.39%) and basic earnings per share $1.63 vs $1.46 (up 11.64%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, International Flavors & Fragrances reported revenue of $3,398.72MM vs $3,116.35MM (up 9.06%) and basic earnings per share $3.73 vs $5.07 (down 26.43%). International Flavors & Fragrances is expected to report earnings on August 14th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.50. The estimated EPS forecast for the next fiscal year is $6.79 and is expected to report on February 13th, 2019.

To read the full International Flavors & Fragrances, Inc. (IFF) report, download it here: https://Fundamental-Markets.com/register/?so=IFF

-----------------------------------------

Pandora Media, Inc. (P) REPORT OVERVIEW

Pandora Media's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Pandora Media reported revenue of $319.23MM vs $316.00MM (up 1.02%) and basic earnings per share -$0.55 vs -$0.56. For the twelve months ended December 31st, 2017 vs December 31st, 2016, Pandora Media reported revenue of $1,466.81MM vs $1,384.83MM (up 5.92%) and basic earnings per share -$2.29 vs -$1.49.

To read the full Pandora Media, Inc. (P) report, download it here: https://Fundamental-Markets.com/register/?so=P

-----------------------------------------

Express Scripts Holding Company (ESRX) REPORT OVERVIEW

Express Scripts Holding's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, Express Scripts Holding reported revenue of $24,769.40MM vs $24,654.90MM (up 0.46%) and basic earnings per share $1.11 vs $0.91 (up 21.98%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, Express Scripts Holding reported revenue of $100,064.60MM vs $100,287.50MM (down 0.22%) and basic earnings per share $7.79 vs $5.43 (up 43.46%). Express Scripts Holding is expected to report earnings on July 24th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $1.73. The estimated EPS forecast for the next fiscal year is $9.54 and is expected to report on February 26th, 2019.

To read the full Express Scripts Holding Company (ESRX) report, download it here: https://Fundamental-Markets.com/register/?so=ESRX

-----------------------------------------

United Continental Holdings, Inc. (UAL) REPORT OVERVIEW

United Continental's Recent Financial Performance

For the three months ended March 31st, 2018 vs March 31st, 2017, United Continental reported revenue of $9,032.00MM vs $8,426.00MM (up 7.19%) and basic earnings per share $0.52 vs $0.32 (up 62.50%). For the twelve months ended December 31st, 2017 vs December 31st, 2016, United Continental reported revenue of $37,736.00MM vs $36,556.00MM (up 3.23%) and basic earnings per share $7.04 vs $6.86 (up 2.62%). United Continental is expected to report earnings on July 17th, 2018. The report will be for the fiscal period ending June 30th, 2018. The reported EPS for the same quarter last year was $2.75. The estimated EPS forecast for the next fiscal year is $9.42 and is expected to report on January 22nd, 2019.

To read the full United Continental Holdings, Inc. (UAL) report, download it here: https://Fundamental-Markets.com/register/?so=UAL

-----------------------------------------

ABOUT Fundamental Markets

Fundamental Markets serves thousands of members and have provided research through some of the world's leading brokerages for over a decade–and continue to be one of the best information sources for investors and investment professionals worldwide. Fundamental Markets' roster boasts decades of financial experience and includes top financial writers, FINRA® BrokerCheck® certified professionals with current and valid CRD® number designations, as well as Chartered Financial Analyst® (CFA®) designation holders, to ensure up to date factual information for active readers on the topics they care about.

REGISTERED MEMBER STATUS

Fundamental Markets' oversight and audit staff are registered analysts, brokers, and/or financial advisers ("Registered Members") working within Equity Research, Media, and Compliance departments. Fundamental Markets' roster includes qualified CFA® charterholders, licensed securities attorneys, and registered FINRA® members holding duly issued CRD® numbers. Current licensed status of several Registered Members at Fundamental Markets have been independently verified by an outside audit firm, including policy and audit records duly executed by Registered Members. Complaints, concerns, questions, or inquiries regarding this release should be directed to Fundamental Markets' Compliance department by Phone, at +1 667-401-0010, or by E-mail at compliance@Fundamental-Markets.com.

LEGAL NOTICES

Information contained herein is not an offer or solicitation to buy, hold, or sell any security. Fundamental Markets, Fundamental Markets members, and/or Fundamental Markets affiliates are not responsible for any gains or losses that result from the opinions expressed. Fundamental Markets makes no representations as to the completeness, accuracy, or timeliness of the material provided and all materials are subject to change without notice. Fundamental Markets has not been compensated for the publication of this press release by any of the above mentioned companies. Fundamental Markets is not a financial advisory firm, investment adviser, or broker-dealer, and does not undertake any activities that would require such registration. For our full disclaimer, disclosure, and terms of service please visit our website.

Media Contact:
Andrew Duffie, Media Department
Office: +1 667-401-0010
E-mail: media@Fundamental-Markets.com

© 2018 Fundamental Markets. All Rights Reserved. For republishing permissions, please contact a partner network manager at partnership@Fundamental-Markets.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

FINRA®, BrokerCheck®, and CRD® are registered trademarks owned by Financial Industry Regulatory Authority, Inc.

Primary Logo

Latest news
Related news
Related shares
Express Scripts Holding Compan
VOL 5,821,513
98.95 USD
0.00 / 0.00 %

Southern Company (The)
VOL 1,769,047
47.55 USD
0.54 / 1.15 %

Pandora Media Inc
VOL 1,568,703
8.730 USD
0.00 / 0.00 %

AcelRx Pharmaceuticals Inc
VOL 905,808
2.870 USD
0.00 / 0.00 %

Internationa Flavors & Fra
VOL 247,472
135.53 USD
-1.20 / -0.88 %